Brind.

Director Jason Haas sold shares of Ligand Pharmaceuticals on September 13, 2026, which traded on the Nasdaq.

1 report, 1 independent Updated Sep 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Director Jason Haas sold shares of Ligand Pharmaceuticals on September 13, 2026, which traded on the Nasdaq.

Who's involved

What this event is mainly about
Jason HaasLigand Pharmaceuticals

Keep exploring

The entities involved

  • Jason Haas

    college basketball player (2003–2006) Stanford

    Nothing else this week.

  • Ligand Pharmaceuticals

    biopharmaceutical company based out of La Jolla, California

    Nothing else this week.

Coverage

Newest first; wire copies grouped